Company news
BridgeBio Pharma, Inc. news in 2019
BridgeBio Pharma, Inc.'s news releases, calls and decks from 2019, newest first.
BridgeBio Pharma’s Origin Biosciences Enters Partnership With Medison to Commercialize BBP-870 in Israel for MoCD Type A
December 17, 2019
BridgeBio Pharma, Inc. Appoints Industry Leader Jennifer Cook as New Board Member
December 15, 2019
BridgeBio Pharma, Inc. Appoints Eli Wallace as Chief Scientific Officer in Residence for Oncology Programs
December 8, 2019
BridgeBio Pharma’s Origin Biosciences Initiates Rolling Submission of New Drug Application with the U.S. FDA for BBP-870 for the Treatment of MoCD Type A
December 2, 2019
BridgeBio Pharma Reports Third Quarter 2019 Financial Results and Highlights Portfolio Progress
November 6, 2019
BridgeBio Pharma Gene Therapy Subsidiaries Present Data Demonstrating Potential in Two Rare Disease Indications at the European Society of Gene and Cell Therapy Conference
October 21, 2019
BridgeBio Pharma Terminates Merger Process With Its Subsidiary Eidos Therapeutics
October 13, 2019